tyo:4282
|
3672776
|
Apr 21st, 2024 12:00AM
|
EPS Corporation(formerly EPS International), a full-service Japan-headquartered CRO
|
954
|
95.00
|
Open
|
|
Apr 21st, 2024 08:31AM
|
Apr 21st, 2024 08:31AM
|
EPS International will merge with EPS Corporation, an EPS Holdings Group company, on September 1, 2022. The merger of these two EPS Group companies will provide enhanced synergistic full CRO services for all worldwide pharmaceutical, biotechnology, medical device companies planning to conduct clinical studies in Japan and Asia Pacific.”
Please visit the EPS Corporation LinkedIn page for more information: https://lnkd.in/gyYxR8Q9
|
Open
|
Clinical Project Management, Contract Research Organization, Site Management Organization, Drug Discovery, Drug Development, Phase I-IV , Post Marketing Surveillance , Pharmacovigilance, Medical Writing, Clinical In-sourcing Provision , and Asia Study
|
Open
|
8th Fl, Kagurazaka AK Bldg., 1-8,
|
Shinjuku-ku,
|
Tokyo
|
JP
|
1620821
|
|
EPS International
|
|
|
tyo:4282
|
3672776
|
Apr 20th, 2024 12:00AM
|
EPS Corporation(formerly EPS International), a full-service Japan-headquartered CRO
|
953
|
95.00
|
Open
|
|
Apr 20th, 2024 07:28AM
|
Apr 20th, 2024 11:35PM
|
EPS International will merge with EPS Corporation, an EPS Holdings Group company, on September 1, 2022. The merger of these two EPS Group companies will provide enhanced synergistic full CRO services for all worldwide pharmaceutical, biotechnology, medical device companies planning to conduct clinical studies in Japan and Asia Pacific.”
Please visit the EPS Corporation LinkedIn page for more information: https://lnkd.in/gyYxR8Q9
|
Open
|
Clinical Project Management, Contract Research Organization, Site Management Organization, Drug Discovery, Drug Development, Phase I-IV , Post Marketing Surveillance , Pharmacovigilance, Medical Writing, Clinical In-sourcing Provision , and Asia Study
|
Open
|
8th Fl, Kagurazaka AK Bldg., 1-8,
|
Shinjuku-ku,
|
Tokyo
|
JP
|
1620821
|
|
EPS International
|
|
|
tyo:4282
|
3672776
|
Apr 19th, 2024 12:00AM
|
EPS Corporation(formerly EPS International), a full-service Japan-headquartered CRO
|
953
|
95.00
|
Open
|
|
Apr 19th, 2024 10:00AM
|
Apr 19th, 2024 10:00AM
|
EPS International will merge with EPS Corporation, an EPS Holdings Group company, on September 1, 2022. The merger of these two EPS Group companies will provide enhanced synergistic full CRO services for all worldwide pharmaceutical, biotechnology, medical device companies planning to conduct clinical studies in Japan and Asia Pacific.”
Please visit the EPS Corporation LinkedIn page for more information: https://lnkd.in/gyYxR8Q9
|
Open
|
Clinical Project Management, Contract Research Organization, Site Management Organization, Drug Discovery, Drug Development, Phase I-IV , Post Marketing Surveillance , Pharmacovigilance, Medical Writing, Clinical In-sourcing Provision , and Asia Study
|
Open
|
8th Fl, Kagurazaka AK Bldg., 1-8,
|
Shinjuku-ku,
|
Tokyo
|
JP
|
1620821
|
|
EPS International
|
|
|
tyo:4282
|
3672776
|
Apr 18th, 2024 12:00AM
|
EPS Corporation(formerly EPS International), a full-service Japan-headquartered CRO
|
952
|
95.00
|
Open
|
|
Apr 18th, 2024 08:39AM
|
Apr 19th, 2024 06:25AM
|
EPS International will merge with EPS Corporation, an EPS Holdings Group company, on September 1, 2022. The merger of these two EPS Group companies will provide enhanced synergistic full CRO services for all worldwide pharmaceutical, biotechnology, medical device companies planning to conduct clinical studies in Japan and Asia Pacific.”
Please visit the EPS Corporation LinkedIn page for more information: https://lnkd.in/gyYxR8Q9
|
Open
|
Clinical Project Management, Contract Research Organization, Site Management Organization, Drug Discovery, Drug Development, Phase I-IV , Post Marketing Surveillance , Pharmacovigilance, Medical Writing, Clinical In-sourcing Provision , and Asia Study
|
Open
|
8th Fl, Kagurazaka AK Bldg., 1-8,
|
Shinjuku-ku,
|
Tokyo
|
JP
|
1620821
|
|
EPS International
|
|
|
tyo:4282
|
3672776
|
Apr 17th, 2024 12:00AM
|
EPS Corporation(formerly EPS International), a full-service Japan-headquartered CRO
|
951
|
95.00
|
Open
|
|
Apr 17th, 2024 10:01AM
|
Apr 17th, 2024 08:40PM
|
EPS International will merge with EPS Corporation, an EPS Holdings Group company, on September 1, 2022. The merger of these two EPS Group companies will provide enhanced synergistic full CRO services for all worldwide pharmaceutical, biotechnology, medical device companies planning to conduct clinical studies in Japan and Asia Pacific.”
Please visit the EPS Corporation LinkedIn page for more information: https://lnkd.in/gyYxR8Q9
|
Open
|
Clinical Project Management, Contract Research Organization, Site Management Organization, Drug Discovery, Drug Development, Phase I-IV , Post Marketing Surveillance , Pharmacovigilance, Medical Writing, Clinical In-sourcing Provision , and Asia Study
|
Open
|
8th Fl, Kagurazaka AK Bldg., 1-8,
|
Shinjuku-ku,
|
Tokyo
|
JP
|
1620821
|
|
EPS International
|
|
|
tyo:4282
|
3672776
|
Apr 16th, 2024 12:00AM
|
EPS Corporation(formerly EPS International), a full-service Japan-headquartered CRO
|
949
|
95.00
|
Open
|
|
Apr 16th, 2024 07:35AM
|
Apr 16th, 2024 04:58PM
|
EPS International will merge with EPS Corporation, an EPS Holdings Group company, on September 1, 2022. The merger of these two EPS Group companies will provide enhanced synergistic full CRO services for all worldwide pharmaceutical, biotechnology, medical device companies planning to conduct clinical studies in Japan and Asia Pacific.”
Please visit the EPS Corporation LinkedIn page for more information: https://lnkd.in/gyYxR8Q9
|
Open
|
Clinical Project Management, Contract Research Organization, Site Management Organization, Drug Discovery, Drug Development, Phase I-IV , Post Marketing Surveillance , Pharmacovigilance, Medical Writing, Clinical In-sourcing Provision , and Asia Study
|
Open
|
8th Fl, Kagurazaka AK Bldg., 1-8,
|
Shinjuku-ku,
|
Tokyo
|
JP
|
1620821
|
|
EPS International
|
|
|
tyo:4282
|
3672776
|
Apr 15th, 2024 12:00AM
|
EPS Corporation(formerly EPS International), a full-service Japan-headquartered CRO
|
949
|
95.00
|
Open
|
|
Apr 15th, 2024 10:21AM
|
Apr 15th, 2024 11:50PM
|
EPS International will merge with EPS Corporation, an EPS Holdings Group company, on September 1, 2022. The merger of these two EPS Group companies will provide enhanced synergistic full CRO services for all worldwide pharmaceutical, biotechnology, medical device companies planning to conduct clinical studies in Japan and Asia Pacific.”
Please visit the EPS Corporation LinkedIn page for more information: https://lnkd.in/gyYxR8Q9
|
Open
|
Clinical Project Management, Contract Research Organization, Site Management Organization, Drug Discovery, Drug Development, Phase I-IV , Post Marketing Surveillance , Pharmacovigilance, Medical Writing, Clinical In-sourcing Provision , and Asia Study
|
Open
|
8th Fl, Kagurazaka AK Bldg., 1-8,
|
Shinjuku-ku,
|
Tokyo
|
JP
|
1620821
|
|
EPS International
|
|
|
tyo:4282
|
3672776
|
Apr 14th, 2024 12:00AM
|
EPS Corporation(formerly EPS International), a full-service Japan-headquartered CRO
|
948
|
95.00
|
Open
|
|
Apr 14th, 2024 06:22AM
|
Apr 14th, 2024 06:22AM
|
EPS International will merge with EPS Corporation, an EPS Holdings Group company, on September 1, 2022. The merger of these two EPS Group companies will provide enhanced synergistic full CRO services for all worldwide pharmaceutical, biotechnology, medical device companies planning to conduct clinical studies in Japan and Asia Pacific.”
Please visit the EPS Corporation LinkedIn page for more information: https://lnkd.in/gyYxR8Q9
|
Open
|
Clinical Project Management, Contract Research Organization, Site Management Organization, Drug Discovery, Drug Development, Phase I-IV , Post Marketing Surveillance , Pharmacovigilance, Medical Writing, Clinical In-sourcing Provision , and Asia Study
|
Open
|
8th Fl, Kagurazaka AK Bldg., 1-8,
|
Shinjuku-ku,
|
Tokyo
|
JP
|
1620821
|
|
EPS International
|
|
|
tyo:4282
|
3672776
|
Apr 13th, 2024 12:00AM
|
EPS Corporation(formerly EPS International), a full-service Japan-headquartered CRO
|
949
|
95.00
|
Open
|
|
Apr 13th, 2024 05:16AM
|
Apr 13th, 2024 05:17PM
|
EPS International will merge with EPS Corporation, an EPS Holdings Group company, on September 1, 2022. The merger of these two EPS Group companies will provide enhanced synergistic full CRO services for all worldwide pharmaceutical, biotechnology, medical device companies planning to conduct clinical studies in Japan and Asia Pacific.”
Please visit the EPS Corporation LinkedIn page for more information: https://lnkd.in/gyYxR8Q9
|
Open
|
Clinical Project Management, Contract Research Organization, Site Management Organization, Drug Discovery, Drug Development, Phase I-IV , Post Marketing Surveillance , Pharmacovigilance, Medical Writing, Clinical In-sourcing Provision , and Asia Study
|
Open
|
8th Fl, Kagurazaka AK Bldg., 1-8,
|
Shinjuku-ku,
|
Tokyo
|
JP
|
1620821
|
|
EPS International
|
|
|
tyo:4282
|
3672776
|
Apr 12th, 2024 12:00AM
|
EPS Corporation(formerly EPS International), a full-service Japan-headquartered CRO
|
948
|
95.00
|
Open
|
|
Apr 12th, 2024 05:29AM
|
Apr 12th, 2024 02:25PM
|
EPS International will merge with EPS Corporation, an EPS Holdings Group company, on September 1, 2022. The merger of these two EPS Group companies will provide enhanced synergistic full CRO services for all worldwide pharmaceutical, biotechnology, medical device companies planning to conduct clinical studies in Japan and Asia Pacific.”
Please visit the EPS Corporation LinkedIn page for more information: https://lnkd.in/gyYxR8Q9
|
Open
|
Clinical Project Management, Contract Research Organization, Site Management Organization, Drug Discovery, Drug Development, Phase I-IV , Post Marketing Surveillance , Pharmacovigilance, Medical Writing, Clinical In-sourcing Provision , and Asia Study
|
Open
|
8th Fl, Kagurazaka AK Bldg., 1-8,
|
Shinjuku-ku,
|
Tokyo
|
JP
|
1620821
|
|
EPS International
|
|
|